These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11585696)

  • 1. Clinical trials of ayurvedic formulations in the treatment of acne vulgaris.
    Lalla JK; Nandedkar SY; Paranjape MH; Talreja NB
    J Ethnopharmacol; 2001 Nov; 78(1):99-102. PubMed ID: 11585696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of four Ayurvedic formulations in the treatment of acne vulgaris: a double-blind randomised placebo-controlled clinical evaluation.
    Paranjpe P; Kulkarni PH
    J Ethnopharmacol; 1995 Dec; 49(3):127-32. PubMed ID: 8824737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of herbal medicine for dysmenorrhea treatment on accompanied acne vulgaris: a study protocol for a randomized controlled trial.
    Kim KI; Nam HJ; Kim M; Lee J; Kim K
    BMC Complement Altern Med; 2017 Jun; 17(1):318. PubMed ID: 28623918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
    Feldman SR; Werner CP; Alió Saenz AB
    J Drugs Dermatol; 2013 Apr; 12(4):438-46. PubMed ID: 23652892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
    Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
    Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
    Draelos ZD; Shalita AR; Thiboutot D; Oresajo C; Yatskayer M; Raab S
    Cutis; 2012 Jun; 89(6):287-93. PubMed ID: 22838094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial.
    Woolery-Lloyd H; Baumann L; Ikeno H
    J Cosmet Dermatol; 2010 Mar; 9(1):22-7. PubMed ID: 20367669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
    Thiboutot D; Arsonnaud S; Soto P
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Effects of Oral and Topical Simvastatin in the Treatment of Acne Vulgaris: A Double-blind, Randomized, Placebo-controlled Clinical Trial.
    Ahmadvand A; Yazdanfar A; Yasrebifar F; Mohammadi Y; Mahjub R; Mehrpooya M
    Curr Clin Pharmacol; 2018; 13(4):279-283. PubMed ID: 30129417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botanical and phytochemical therapy of acne: a systematic review.
    Fisk WA; Lev-Tov HA; Sivamani RK
    Phytother Res; 2014 Aug; 28(8):1137-52. PubMed ID: 25098271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
    Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.
    Jarratt MT; Brundage T
    J Drugs Dermatol; 2012 Mar; 11(3):318-26. PubMed ID: 22395582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
    Pariser D; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s18-23. PubMed ID: 18575222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
    Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.
    Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S;
    J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.